drugset / Trial / NCT02416063

Caudal Versus Intravenous Dexmedetomidine for Caudal Analgesia in Children

NCT02416063

Phase 2 Completed 75 enrolled University of Jordan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this prospective randomized double-blind study was to compare the analgesic efficacy and the side effects of dexmedetomidine (1 µg.kg-1) co-administered with bupivacaine for caudal analgesia or intravenously in children undergoing infra-umbilical surgery.

Timeline

Start
2014-01
Primary completion
2014-10
Completion
2014-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Other
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Sevoflurane Other / unclassified Inhaled

Indications

No indication recorded.